Lan Wei
14Patents
4h-index
55Co-inventors
59Inventor score
Filing activity: Apr 29, 2005 → Aug 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9290517B2 | Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives | Human Necessities | 6 | Active |
| US8796258B2 | Cyclic azabenzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 5 | Active |
| US9527839B2 | Benzimidazole tetrahydropyran derivatives | Chemistry; Metallurgy | 5 | Active |
| US9540364B2 | Benzimidazole tetrahydrofuran derivatives | Chemistry; Metallurgy | 5 | Active |
| US9382243B2 | Azabenzimidazole tetrahydropyran derivatives | Human Necessities | 4 | Active |
| US9868733B2 | Azabenzimidazole tetrahydrofuran derivatives | Chemistry; Metallurgy | 4 | Active |
| US9556193B2 | Benzimidazole hexahydrofuro[3,2-b]furan derivatives | Human Necessities | 4 | Active |
| US8853212B2 | Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes | Chemistry; Metallurgy | 3 | Active |
| US11680060B2 | Bicycloheptane pyrrolidine orexin receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US12312332B2 | Heteroaryl pyrrolidine and piperidine orexin receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US12304899B2 | Factor XI activation inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9029377B2 | Platelet-activating factor receptor antagonists | Physics | 0 | Active |
| US7687492B2 | 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | Chemistry; Metallurgy | 0 | Active |
| US12428397B2 | Factor XI activation inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.